Analysis of Lenvatinib's Efficacy against Intermediate-Stage Unresectable Hepatocellular Carcinoma.

MLA

Amioka, Kei, et al. “Analysis of Lenvatinib’s Efficacy against Intermediate-Stage Unresectable Hepatocellular Carcinoma.” Cancers, vol. 14, no. 20, Oct. 2022. EBSCOhost, https://doi.org/10.3390/cancers14205066.

APA

Amioka, K., Kawaoka, T., Kinami, T., Yamasaki, S., Kosaka, M., Johira, Y., Yano, S., Naruto, K., Ando, Y., Fujii, Y., Uchikawa, S., Ono, A., Yamauchi, M., Imamura, M., Kosaka, Y., Ohya, K., Mori, N., Takaki, S., Tsuji, K., … Oka, S. (2022). Analysis of Lenvatinib’s Efficacy against Intermediate-Stage Unresectable Hepatocellular Carcinoma. Cancers, 14(20). https://doi.org/10.3390/cancers14205066

Chicago

Amioka, Kei, Tomokazu Kawaoka, Takahiro Kinami, Shintaro Yamasaki, Masanari Kosaka, Yusuke Johira, Shigeki Yano, et al. 2022. “Analysis of Lenvatinib’s Efficacy against Intermediate-Stage Unresectable Hepatocellular Carcinoma.” Cancers 14 (20). doi:10.3390/cancers14205066.